scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...999785F |
P356 | DOI | 10.1371/JOURNAL.PONE.0099785 |
P932 | PMC publication ID | 4072672 |
P698 | PubMed publication ID | 24968098 |
P5875 | ResearchGate publication ID | 263433183 |
P50 | author | Matthias Blüher | Q15431947 |
Anke Tönjes | Q28805355 | ||
Michael Stumvoll | Q30434795 | ||
Byung-Soo Youn | Q57029869 | ||
Nora Klöting | Q64495140 | ||
Mathias Fasshauer | Q64495185 | ||
Markus Scholz | Q88687547 | ||
Gesine Flehmig | Q114332626 | ||
P2860 | cites work | Adipose tissue dysfunction in obesity | Q34974909 |
Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention | Q35688384 | ||
Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine | Q36182471 | ||
Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 | ||
Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study | Q36541754 | ||
Ectopic fat accumulation and metabolic syndrome | Q36697732 | ||
Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program | Q36862877 | ||
Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue | Q37105317 | ||
Insulin and metformin regulate circulating and adipose tissue chemerin | Q37317478 | ||
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). | Q37371843 | ||
Adiponectin: mechanistic insights and clinical implications | Q38017897 | ||
Adipose tissue dysfunction contributes to obesity related metabolic diseases | Q38111530 | ||
Serum adiponectin is related to plasma high-density lipoprotein cholesterol but not to plasma insulin-concentration in healthy children: the FLVS II study | Q39766174 | ||
Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis. | Q41881060 | ||
PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue | Q42801261 | ||
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes | Q42819615 | ||
Insulin-sensitive obesity | Q43008676 | ||
Prevalence of undiagnosed diabetes and impaired glucose regulation in 35-59-year-old individuals in Southern Germany: the KORA F4 Study | Q43034862 | ||
Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans | Q43187554 | ||
Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome | Q43746704 | ||
Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance | Q44039988 | ||
Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts | Q44262723 | ||
Adiponectin and protection against type 2 diabetes mellitus | Q44290932 | ||
Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models | Q45342391 | ||
Metabolically healthy but obese women: effect of an energy-restricted diet | Q46574442 | ||
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans | Q46722513 | ||
Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes | Q46812369 | ||
Serum vaspin concentrations in human obesity and type 2 diabetes | Q46908191 | ||
Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome | Q47190662 | ||
Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity | Q47340509 | ||
The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies | Q21256400 | ||
Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids | Q24297055 | ||
Retinol-binding protein 4 in human obesity | Q24304905 | ||
Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism | Q24320019 | ||
Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity | Q24532873 | ||
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure | Q24652521 | ||
Adiponectin, driver or passenger on the road to insulin sensitivity? | Q26827971 | ||
Inflammation and metabolic disorders | Q27860923 | ||
Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia | Q30497410 | ||
Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes | Q33749786 | ||
Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. | Q33751624 | ||
Circulating omentin concentration increases after weight loss | Q33810842 | ||
Leptin | Q33904994 | ||
The perils of portliness: causes and consequences of visceral adiposity | Q33906781 | ||
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia | Q33946056 | ||
Correlation between serum resistin level and adiposity in obese individuals | Q33967739 | ||
Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. | Q34244082 | ||
Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome | Q34355173 | ||
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 | ||
Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome | Q34586253 | ||
Mechanisms linking obesity with cardiovascular disease | Q34590832 | ||
Chemerin is a novel adipokine associated with obesity and metabolic syndrome | Q34653815 | ||
Association between serum retinol-binding protein 4 concentrations and clinical indices in subjects with type 2 diabetes: a meta-analysis. | Q50496197 | ||
Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. | Q50893677 | ||
Relationship between vaspin gene expression and abdominal fat distribution of Korean women. | Q51372374 | ||
Serum bone morphogenetic protein 7, insulin resistance, and insulin secretion in non-diabetic individuals. | Q51375491 | ||
Preadipocyte factor-1 is associated with metabolic profile in severe obesity | Q51381274 | ||
A novel surrogate index for hepatic insulin resistance. | Q51386060 | ||
Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. | Q51388002 | ||
High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. | Q51479802 | ||
Pvclust: an R package for assessing the uncertainty in hierarchical clustering. | Q51630850 | ||
BAT: a new target for human obesity? | Q53344276 | ||
Omentin plasma levels and gene expression are decreased in obesity. | Q55043420 | ||
Visceral Fat Is an Independent Predictor of All-cause Mortality in Men* | Q57693125 | ||
Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass | Q80586267 | ||
Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study | Q85046662 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | preproinsulin | Q7240673 |
inflammation | Q101991 | ||
P304 | page(s) | e99785 | |
P577 | publication date | 2014-06-26 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation | |
P478 | volume | 9 |
Q38940440 | Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss |
Q48046042 | Association between inflammatory potential of diet and risk of depression in middle-aged women: the Australian Longitudinal Study on Women's Health |
Q36235598 | Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus |
Q37226216 | Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women |
Q39391000 | C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation |
Q58828952 | Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls |
Q92989351 | Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients |
Q41400198 | Dietary inflammatory index, cardiometabolic conditions and depression in the Seguimiento Universidad de Navarra cohort study |
Q54979048 | Early diagnosis of type 2 diabetes based on multiple biomarkers and non-invasive indices. |
Q61449679 | Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity |
Q51034427 | Experimental type 2 diabetes induction reduces serum vaspin, but not serum omentin, in Wistar rats. |
Q51495203 | Growth promotion in pigs by oxytetracycline coincides with down regulation of serum inflammatory parameters and of hibernation-associated protein HP-27. |
Q46824924 | Identification of novel adipokines differential regulated in C57BL/Ks and C57BL/6. |
Q93181890 | Is there a causal relationship between obesity and puberty? |
Q37125726 | Is vaspin related to cardio-metabolic status and autonomic function in early stages of glucose intolerance and in metabolic syndrome? |
Q92569776 | MicroRNAs in Obesity and Related Metabolic Disorders |
Q35679964 | Multi-Biomarkers for Early Detection of Type 2 Diabetes, Including 10- and 12-(Z,E)-Hydroxyoctadecadienoic Acids, Insulin, Leptin, and Adiponectin |
Q90276777 | Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation and insulin resistance in mice with diet-induced obesity |
Q35827213 | Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes |
Q40292640 | Novel adipokines: methodological utility in human obesity research |
Q27000369 | Obesity as an emerging risk factor for iron deficiency |
Q36764863 | Preadipocyte factor 1 induces pancreatic ductal cell differentiation into insulin-producing cells. |
Q91928970 | Principal component analysis of adipocytokines and insulin associate with risk factors of cardiovascular diseases |
Q38831044 | Progranulin: A key player in autoimmune diseases. |
Q36548318 | Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury |
Q48341637 | Serum glypican 4 level in obese children and its relation to degree of obesity |
Q40684743 | Serum preadipocyte factor 1 concentrations and risk of developing diabetes: a nested case-control study |
Q88968448 | Short-Term Impact of Laparoscopic Sleeve Gastrectomy on Serum Cartonectin and Vaspin Levels in Obese Subjects |
Q92856084 | The association between omentin and diabetes: a systematic review and meta-analysis of observational studies |
Q42733670 | The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study |
Q61798090 | The cartonectin levels at different stages of chronic kidney disease and related factors |
Q92429233 | The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake |
Q26772301 | The role of progranulin in diabetes and kidney disease |
Q28553583 | Uncovering Factors Related to Pancreatic Beta-Cell Function |
Search more.